290 related articles for article (PubMed ID: 17350710)
1. The metabolic syndrome in Australia: prevalence using four definitions.
Cameron AJ; Magliano DJ; Zimmet PZ; Welborn T; Shaw JE
Diabetes Res Clin Pract; 2007 Sep; 77(3):471-8. PubMed ID: 17350710
[TBL] [Abstract][Full Text] [Related]
2. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions.
Nilsson PM; Engström G; Hedblad B
Diabet Med; 2007 May; 24(5):464-72. PubMed ID: 17381496
[TBL] [Abstract][Full Text] [Related]
3. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
[TBL] [Abstract][Full Text] [Related]
5. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP
Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335
[TBL] [Abstract][Full Text] [Related]
6. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
[TBL] [Abstract][Full Text] [Related]
7. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
Song SH; Hardisty CA
QJM; 2008 Jun; 101(6):487-91. PubMed ID: 18353792
[TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome and cardiovascular risk: implications for clinical practice.
Eddy DM; Schlessinger L; Heikes K
Int J Obes (Lond); 2008 May; 32 Suppl 2():S5-10. PubMed ID: 18469838
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions.
Zabetian A; Hadaegh F; Azizi F
Diabetes Res Clin Pract; 2007 Aug; 77(2):251-7. PubMed ID: 17234299
[TBL] [Abstract][Full Text] [Related]
13. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome.
Benetos A; Thomas F; Pannier B; Bean K; Jégo B; Guize L
Am J Cardiol; 2008 Jul; 102(2):188-91. PubMed ID: 18602519
[TBL] [Abstract][Full Text] [Related]
14. Inverse associations between muscle mass, strength, and the metabolic syndrome.
Atlantis E; Martin SA; Haren MT; Taylor AW; Wittert GA;
Metabolism; 2009 Jul; 58(7):1013-22. PubMed ID: 19394973
[TBL] [Abstract][Full Text] [Related]
15. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
[TBL] [Abstract][Full Text] [Related]
16. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study.
Dekker JM; Girman C; Rhodes T; Nijpels G; Stehouwer CD; Bouter LM; Heine RJ
Circulation; 2005 Aug; 112(5):666-73. PubMed ID: 16061755
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of metabolic syndrome at age 16 using the International Diabetes Federation paediatric definition.
Pirkola J; Tammelin T; Bloigu A; Pouta A; Laitinen J; Ruokonen A; Tapanainen P; Järvelin MR; Vääräsmäki M
Arch Dis Child; 2008 Nov; 93(11):945-51. PubMed ID: 18456683
[TBL] [Abstract][Full Text] [Related]
19. Hyperhomocysteinemia, coronary heart disease, and diabetes mellitus as predicted by various definitions for metabolic syndrome in a hypertensive Saudi population.
Al-Daghri NM
Saudi Med J; 2007 Mar; 28(3):339-46. PubMed ID: 17334456
[TBL] [Abstract][Full Text] [Related]
20. The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius.
Cameron AJ; Zimmet PZ; Soderberg S; Alberti KG; Sicree R; Tuomilehto J; Chitson P; Shaw JE
Diabet Med; 2007 Dec; 24(12):1460-9. PubMed ID: 17976203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
